Quantcast

Latest pharmaceutical Stories

2014-09-16 23:13:20

InTouchMD™ launches innovative social media tool that allows pharmaceutical companies and physicians to better connect with their patients. Garden City, NY (PRWEB) September 16, 2014 InTouchMD, a New York based multi-channel contact center dedicated to serving the healthcare industry, has launched a revolutionary service that gives pharmaceutical companies the ability to connect to their patients through social media in order to foster better patient diagnostics and care. “We have...

2014-09-16 08:29:41

Clinical Trials Mark Important Milestone in Development of Two Highly Complex Products PITTSBURGH, Sept. 16, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL), one of the world's leading global pharmaceutical companies, today announced it is initiating Phase III clinical trials for its generic version of GlaxoSmithKline's Advair Diskus® and its insulin analog to Sanofi's Lantus®. http://photos.prnewswire.com/prnvar/20140423/77793 In October 2014, Mylan will commence a Phase III...

2014-09-16 04:21:18

WHIPPANY, N.J., Sept. 16, 2014 /PRNewswire/ -- Bayer HealthCare and Orion Corporation, a pharmaceutical company based in Espoo, Finland, have begun to enroll patients in a Phase III trial with ODM-201, an investigational oral androgen receptor inhibitor in clinical development. The study, called ARAMIS, evaluates ODM-201 in men with castration-resistant prostate cancer who have rising Prostate Specific Antigen (PSA) levels and no detectable metastases. The trial is designed to...

2014-09-09 12:29:19

MENLO PARK, Calif., Sept. 9, 2014 /PRNewswire/ -- SRI International, an independent nonprofit research institute, and Nobelpharma, a Japanese pharmaceutical company, have entered into a licensing agreement to test SR16234, an SRI drug candidate that may be effective in treating endometriosis. SR16234 is a member of a class of drugs known as selective estrogen receptor modulators (SERMs) that regulate the effects of the hormone estrogen. "This important collaboration is addressing a...

2014-09-08 12:29:37

WOODBRIDGE, ON, Sept. 8, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the "Company"), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease ("CVD") and overall health, today announced the appointment of Prakash Gowd as the Company's Chief Financial Officer. Mr. Gowd succeeds Eugene Bortoluzzi, who will remain Pivotal's Chief Executive Officer. In addition to having an impressive track record as one...

2014-08-27 12:30:26

Profit Attributable to Owners of the Company Up by 34.4% HONG KONG, Aug. 27, 2014 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd. (HKEx: 0460) ("Sihuan Pharmaceutical" or the "Company"), a leading pharmaceutical company with the largest cardio-cerebral vascular ("CCV") drug franchise in China's prescription drug market, today announced the unaudited consolidated results of the Company and its subsidiaries (collectively the "Group") for the six months ended 30 June 2014...

2014-08-27 08:27:34

MONMOUTH JUNCTION, N.J., Aug. 27, 2014 /PRNewswire/ -- Tris Pharma, a specialty pharmaceutical company focused on developing innovative drug delivery technologies, today announced that it has been selected as an award winner in the New Jersey Business & Industry Association's 2014 Awards for Excellence competition in the Business Expansion category. Finalists were selected by an independent panel of judges from SCORE (Counselors to America's Small Business) and NJBIA member...

2014-08-25 08:27:26

New Indication in Chronic Pain Marks Company's Third FDA Approval in Less Than a Year PHILADELPHIA, Aug. 25, 2014 /PRNewswire/ -- Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced today the United States Food and Drug Administration (FDA) has approved ZORVOLEX® (diclofenac) capsules, a nonsteroidal anti-inflammatory drug (NSAID), for the management of osteoarthritis pain. This marks the second indication...

2014-08-23 04:20:16

DALLAS, August 23, 2014 /PRNewswire/ -- The report titled "Pharmaceutical Packaging Market by Packaging Type (Plastic bottles, Blister packs, Caps & Closures, Ampoules, Vials and Others) Raw Material (Plastics, Paper & Paperboard, Glass, Aluminum foils), and Drug Delivery Type - Global Trends & Forecast to 2018" of 424 pages is now available with LifeScienceIndustryResearch.com. The pharmaceutical packaging report analyzes pharmaceutical packaging market by type...

2014-08-19 16:28:51

DUBLIN, Aug. 19, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Pharmaceutical Contract Manufacturing - Global Strategic Business Report" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 This report analyzes the worldwide markets for Pharmaceutical Contract Manufacturing in US$ Thousand by the following Dosage Forms: Injectables (Injections, Vials, and IV solutions), Solid Dosage Forms (Tablets and Capsules), and Liquid &...


Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related